25
Views
1
CrossRef citations to date
0
Altmetric
Review

Use of gene expression microarrays for the study of acute leukemia

, , &
Pages 733-747 | Published online: 09 Jan 2014

References

  • Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the acute leukaemias. French–American–British (FAB) cooperative group. Br. J. Haematol.33, 451–458 (1976).
  • Bennett JM, Begg CB. Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival. Cancer Res.41, 4833–4837 (1981).
  • Bene MC, Castoldi G, Knapp W et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia9, 1783–1786 (1995).
  • Rowley JD. The role of chromosome translocations in leukemogenesis. Semin. Hematol.36, 59–72 (1999).
  • Ramsay G. DNA chips: state-of-the art. Nat. Biotechnol.16, 40–44 (1998).
  • Amundson SA, Do KT, Shahab S et al. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat. Res.154, 342–346 (2000).
  • Amundson SA, Grace MB, McLeland CB et al. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res.64, 6368–63671 (2004).
  • Mertens BJ. Microarrays, pattern recognition and exploratory data analysis. Stat. Med.22, 1879–1899 (2003).
  • Scharpf R, Garrett ES, Hu J, Parmigiani G. Statistical modeling and visualization of molecular profiles in cancer. Biotechniques Suppl, 22–29 (2003).
  • Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science270, 467–470 (1995).
  • Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science286, 531–537 (1999).
  • Moos PJ, Raetz EA, Carlson MA et al. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin. Cancer Res.8, 3118–3130 (2002).
  • Ross ME, Zhou X, Song G et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood102, 2951–2959 (2003).
  • Kohlmann A, Schoch C, Schnittger S et al. Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia18, 63–71 (2004).
  • Armstrong SA, Staunton JE, Silverman LB et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet.30, 41–47 (2002).
  • Rozovskaia T, Ravid-Amir O, Tillib S et al. Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. Proc. Natl Acad. Sci. USA100, 7853–7858 (2003).
  • Tsutsumi S, Taketani T, Nishimura K et al. Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res.63, 4882–4887 (2003).
  • Yeoh EJ, Ross ME, Shurtleff SA et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell1, 133–143 (2002).
  • Ferrando AA, Neuberg DS, Staunton J et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell1, 75–87 (2002).
  • Stam RW, den Boer ML, Schneider P et al. Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. Blood106, 2484–2490 (2005).
  • Chiaretti S, Li X, Gentlemen R et al. Gene-expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. Clin. Cancer Res.11, 7209–7219 (2005).
  • Virtaneva K, Wright FA, Tanner SM et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc. Natl Acad. Sci. USA98, 1124–1129 (2001).
  • Schoch C, Kohlmann A, Schnittger S et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene-expression profiles. Proc. Natl Acad. Sci. USA99, 10008–10013 (2002).
  • Debernardi S, Lillington DM, Chaplin T et al. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer37, 149–158 (2003).
  • Valk PJ, Verhaak RG, Beijen MA et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med.350, 1617–1628 (2004).
  • Bullinger L, Dohner K, Bair E et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med.350, 1605–1616 (2004).
  • Ross ME, Mahfouz R, Onciu M et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood104, 3679–3687 (2004).
  • Miyazato A, Ueno S, Ohmine K et al. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood98, 422–427 (2001).
  • Ueda M, Ota J, Yamashita Y et al. DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome. Br. J. Haematol.123, 288–296 (2003).
  • Tsutsumi C, Ueda M, Miyazaki Y et al. DNA microarray analysis of dysplastic morphology associated with acute myeloid leukemia. Exp. Hematol.32, 828–835 (2004).
  • Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood100, 3553–3560 (2002).
  • Pellagatti A, Esoof N, Watkins F et al. Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Br. J. Haematol.125, 576–583 (2004).
  • Lacayo NJ, Meshinchi S, Kinnunen P et al. gene-expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. Blood104, 2646–2654 (2004).
  • Neben K, Tews B, Wrobel G et al. Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes. Oncogene23, 2379–2384 (2004).
  • Li H, Luan Y. Kernel Cox regression models for linking gene-expression profiles to censored survival data. Pac. Symp. Biocomput.8, 65–76 (2003).
  • Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature403, 503–511 (2000).
  • Garber ME, Troyanskaya OG, Schluens K et al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA98, 13784–13789 (2001).
  • Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA98, 10869–10874 (2001).
  • Ahmed M, Sternberg A, Hall G et al Natural history of GATA1 mutations in Down syndrome. Blood103, 2480–2489 (2004).
  • McElwaine S, Mulligan C, Groet J et al. Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down’s syndrome, revealing PRAME as a specific discriminating marker. Br. J. Haematol.125, 729–742 (2004).
  • Ohno R, Nakamura Y. Prediction of response to imatinib by cDNA microarray analysis. Semin. Hematol.40(2 Suppl. 3), 42–49 (2003).
  • Hofmann WK, de Vos S, Elashoff D et al. Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study. Lancet359, 481–486 (2002).
  • Tipping AJ, Deininger MW, Goldman JM, Melo JV. Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate. Exp. Hematol.31, 1073–1080 (2003).
  • Fine BM, Kaspers GJ, Ho M, Loonen AH, Boxer LM. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia. Cancer Res.65, 291–299 (2005).
  • Park DJ, Vuong PT, de Vos S, Douer D, Koeffler HP. Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays. Blood102, 3727–3736 (2003).
  • Holleman A, Cheok MH, den Boer ML et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N. Engl. J. Med.351, 533–542 (2004).
  • Lugthart S, Cheok MH, den Boer ML et al. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell7, 375–386 (2005).
  • Cheok MH, Yang W, Pui CH et al. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cell. Nat. Genet.34, 85–90 (2003).
  • Kohlmann A, Schoch C, Dugas M et al. Pattern robustness of diagnostic gene expression signatures in leukemia. Genes Chromosomes Cancer42, 299–307 (2005).
  • Radich JP, Mao M, Stepaniants S et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics83, 980–988 (2004).
  • Nguyen DV, Rocke DM. Tumor classification by partial least squares using microarray gene expression data. Bioinformatics18, 39–50 (2002).
  • Troyanskaya O, Cantor M, Sherlock G et al. Missing value estimation methods for DNA microarrays. Bioinformatics17, 520–525 (2001).
  • Hwang D, Schmitt WA, Stephanopoulos G. Determination of minimum sample size and discriminatory expression patterns in microarray data. Bioinformatics18, 1184–1193 (2002).
  • Staal FJ, van der Burg M, Wessels LF et al. DNA microarrays for comparison of gene-expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers. Leukemia17, 1324–1332 (2003).
  • Brazma A, Hingamp P, Quackenbush J et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet.29, 365–371 (2001).
  • Ball CA, Sherlock G, Parkinson H et al. Microarray Gene Expression Data (MGED) Society. Standards for microarray data. Science298, 539 (2002).
  • Brazma A, Parkinson H, Sarkans U et al. ArrayExpress – a public repository for microarray gene expression data at the EBI. Nucleic Acids Res.31, 68–71 (2003).
  • Lockhart DJ, Dong H, Bryne MC, Folettie MT, Gallo MV, Chee MC. Expression monitoring by hybridization to high-density ologionucleotide arrays. Nat. Biotechnol.14, 1675–1680 (1996).
  • Schena M, Shalon D, Davis RW, Brown PO. Quantiative monitoring of gene expression patterns with a complementary DNA microarray. Science21, 467–470 (1995).
  • Hughes TR, Mao M, Jones AR et al. Expression profiling using microarrays fabricated by an ink-jet oligonuclotide synthesizer. Nat. Biotechnol.19, 342–347 (2001).
  • Yang IV, Chen E, Hasseman JP et al. Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol.3, 1–12 (2002).
  • Antoniadis A, Lambert-Lacroix S, Leblanc F. Effective dimension reduction methods for tumor classification using gene expression data. Bioinformatics19, 563–570 (2003).
  • Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA95, 14863–14868 (1998).
  • Ben-Dor A, Shamir R, Yakhini Z. Clustering gene expression patterns.J. Comput. Biol.6, 281–297 (1999).
  • Smyth GK, Yang YH. Statistical issues in cDNA microarray data analysis. Methods Mol. Biol.224, 111–136 (2003).
  • Vohradsky J. Neural network model of gene expression. FASEB J. 15, 846–854 (2001).
  • Zhao LP, Prentice RL, Breeden LL. Statistical modeling of large microarray data sets to identify stimulus-response profiles. Proc. Natl Acad. Sci.98, 5631–5636 (2001).
  • Getz G, Levine E, Domany E. Coupled two-way clustering analysis of gene microarray data. Proc. Natl Acad. Sci. USA97, 12079–12084 (2000).
  • Tamayo P, Slonim D, Mesirov et al. Interpretting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl Acad. Sci. USA96, 2907–2912 (1999).
  • Brown MPS, Grundy WN, Lin D et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natl Acad. Sci. USA97, 262–264 (2000).
  • Wang J, Bo TH, Jonassen I, Myklebost O, Hovig E. Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. BMC Bioinformatics4, 60 (2003).
  • Liu B, Cui Q, Jiang T, Ma S. A combinatorial feature selection and ensemble neural network method for classification of gene expression data. Bioinformatics5, 136 (2004).
  • Tan Y, Shi L, Tong W, Hwang GT, Wang C. Multi-class tumor classification by discriminant partial least squares using microarray gene expression data and assessment of classification models. Comput. Biol. Chem.28, 235–244 (2004).
  • Desper R, Khan J, Schaffer AA. Tumor classification using phylogenetic methods on expression data. J. Theor. Biol.228, 477–496 (2004).
  • Jensen LJ, Knudsen S. Automatic discovery of regulatory patterns in promoter regions based on whole cell expression data and functional annotation. Bioinformatics16, 326–333 (2000).
  • Qin ZS, McCue LA, Thompson W, Mayerhofer L, Lawrence CE, Liu JS. Identification of co-regulated genes through Bayesian clustering of predicted regulatory binding sites. Nat. Biotechnol.21, 435–39 (2003).

Websites

  • Microarray Gene Expression Data Society www.mged.org
  • National Library of Medicine www.nlm.nih.gov/mesh/MBrowser
  • Microarray Gene Expression Data Society www.mged.org
  • National center for Biotechnology Information www.ncbi.nlm.nih.gov/geo/info/fields.pgi
  • Gene Ontology www.geneontology.org
  • Kyoto Encyclopedia of Genes and Genomes www.genome.ad.jp/kegg/kegg2.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.